$24.39 0.32 (+1.33%)
11/25/2009 11:50 AM

Par Pharmaceutical Companies, Inc. (PRX)

CAPS Rating: 2 out of 5

The Company, through its subsidiary Par Pharmaceutical, Inc., is engaged in the development, manufacture and distribution of generic pharmaceuticals and branded pharmaceuticals in the United States.

Featured Broker Partners